Research Article

Optimization (Central Composite Design) and Validation of HPLC Method for Investigation of Emtricitabine Loaded Poly(lactic-co-glycolic acid) Nanoparticles: In Vitro Drug Release and In Vivo Pharmacokinetic Studies

Table 6

Pharmacokinetic parameters of free emtricitabine and emtricitabine NPs at a dose of 15 mg/kg/rat.

Pharmacokinetic parameters Free emtricitabineEmtricitabine NPs

(µg/mL)1.696 ± 0.0171.934 ± 0.041
(h)2.0 ± 0.006 16 ± 0.031
(h)9.366 ± 0.580 32.099 ± 2.194
AUC (µg/mL*h)14.835 ± 0.450238.667 ± 10.315
AUMC (µg/mL*h)178.32 ± 15.09522156.689 ± 1243.02
(1/h) 0.0741 ± 0.0040.0215 ± 0.0013
MRT12.0 ± 0.67094.307 ± 1.950

Data presented as mean ± standard deviation ( ).